Also categorized in News:
SickKids expert leads editorial calling for paediatric cancer to be made a global child health priority (The Hospital for Sick Children)
x hide permanently

Emerging and investigational therapies for neuroblastoma.

ncbi.nlm.nih.gov

Emerging and investigational therapies for neuroblastoma.

Expert Opin Orphan Drugs. 2017;5(4):355-368

Authors: Applebaum MA, Desai AV, Glade Bender JL, Cohn SL

Abstract INTRODUCTION: Treatment for children with clinically aggressive, high-risk neuroblastoma remains challenging. Less than 50% of patients with high-risk neuroblastoma will survive long-term with current therapies, and survivors are at risk for serious treatment-related late toxicities.

Mentions: Treatment